Lab-Grown mini tumors could guide breast cancer care
NCT ID NCT06468124
First seen Jan 05, 2026 · Last updated Jun 22, 2026 · Updated 24 times
Summary
This study takes tumor samples from breast cancer patients whose cancer has spread to the brain or other organs. Researchers grow these samples into tiny 3D organoids in the lab and test different treatments on them. The goal is to see if the organoids' responses match how the patients actually respond to therapy, which could eventually help personalize treatment choices.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST NEOPLASMS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Guy's and St. Thomas NHS Foundation Trust
RECRUITINGLondon, SE1 9RT, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
King's College Hospital NHS Foundation Trust
RECRUITINGLondon, SE5 9RS, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a lab test that helps doctors choose the most effective treatment for each patient's breast cancer metastases.
What could go wrong
This is a very small, early study with only 20 participants. The organoids may not perfectly predict real patient responses, and results may not apply to all breast cancer patients.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.